2026 Global: Absorbable Suture Market-Competitive Review (2032) report
Description
The 2026 Global: Absorbable Suture Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Major players in the absorbable suture market include Ethicon (HQ: New Brunswick, USA), Medtronic (HQ: Dublin, Ireland), B. Braun Melsungen AG (HQ: Melsungen, Germany), Weigao Group Medical Polymer Co., Ltd. (HQ: Weihai, China), Kanghui Medical Co., Ltd. (HQ: Shanghai, China), Meril Life Sciences Pvt. Ltd. (HQ: Ahmedabad, India), Taewoong Medical Co., Ltd. (HQ: Seoul, Korea), DemeTech Corporation (HQ: Miami, United States), Lohmann & Rauscher (HQ: Rottendorf, Germany), and Teleflex Incorporated (HQ: Wayne, United States). Each entity leverages established manufacturing footprints, regulatory know-how, and distribution networks to supply absorbable sutures based on polymers such as polyglactin, polyglycolic acid, poliglecaprone, and polydioxanone, enabling geographic reach across hospitals and clinics. These firms compete not only on price and supply reliability but also on product performance metrics including knot security, tissue drag, and resorption timelines. The competitive landscape reflects a blend of legacy brands expanding their reach via acquisitions and OEM arrangements.
Ethicon and Medtronic dominate absorbable-suture volumes, with Ethicon (HQ: New Brunswick, USA) offering Vicryl, Monocryl, and PDS for closures. Medtronic (HQ: Dublin, Ireland) uses Covidien-derived absorbables to maintain a portfolio. B. Braun Melsungen AG (HQ: Melsungen, Germany) extends access through regional plants and a diversified supplier network. Weigao Group Medical Polymer Co., Ltd. (HQ: Weihai, China) has scaled suture production to meet APAC demand and is expanding exports. Kanghui Medical Co., Ltd. (HQ: Shanghai, China) supports regional distribution and regulatory alignment in Asian markets. Meril Life Sciences Pvt. Ltd. (HQ: Ahmedabad, India) combines domestic manufacturing with expanding distribution in the Middle East and Africa. Taewoong Medical Co., Ltd. (HQ: Seoul, Korea) emphasizes quality and approvals in Korea. DemeTech Corporation (HQ: Miami, USA) maintains U.S.-centric manufacturing and sales. Lohmann & Rauscher (HQ: Rottendorf, Germany) supplies clinics with standardized sutures. Teleflex Incorporated (HQ: Wayne, USA) complements wound-management with devices for surgical applications.
Across these ten firms, market growth is driven by rising surgery volumes and preferences for predictable resorption timelines with minimal tissue reaction. Core polymers—polyglactin 910, polyglycolic acid, poliglecaprone, and polydioxanone—remain central, with firms investing in formulations balancing handling and knot security. Geographic diversification supports shorter supply chains across the United States, Europe, China, and India, while maintaining regulatory alignment. Quality, sterility, and packaging innovations are key differentiators as reimbursement trends favor value-based care. The ten companies listed—Ethicon (HQ: New Brunswick, USA), Medtronic (HQ: Dublin, Ireland), B. Braun Melsungen AG (HQ: Melsungen, Germany), Weigao Group Medical Polymer Co., Ltd. (HQ: Weihai, China), Kanghui Medical Co., Ltd. (HQ: Shanghai, China), Meril Life Sciences Pvt. Ltd. (HQ: Ahmedabad, India), Taewoong Medical Co., Ltd. (HQ: Seoul, Korea), DemeTech Corporation (HQ: Miami, USA), Lohmann & Rauscher (HQ: Rottendorf, Germany), Teleflex Incorporated (HQ: Wayne, USA)—will continue to influence standards through evidence and compliance in surgical care.
Major players in the absorbable suture market include Ethicon (HQ: New Brunswick, USA), Medtronic (HQ: Dublin, Ireland), B. Braun Melsungen AG (HQ: Melsungen, Germany), Weigao Group Medical Polymer Co., Ltd. (HQ: Weihai, China), Kanghui Medical Co., Ltd. (HQ: Shanghai, China), Meril Life Sciences Pvt. Ltd. (HQ: Ahmedabad, India), Taewoong Medical Co., Ltd. (HQ: Seoul, Korea), DemeTech Corporation (HQ: Miami, United States), Lohmann & Rauscher (HQ: Rottendorf, Germany), and Teleflex Incorporated (HQ: Wayne, United States). Each entity leverages established manufacturing footprints, regulatory know-how, and distribution networks to supply absorbable sutures based on polymers such as polyglactin, polyglycolic acid, poliglecaprone, and polydioxanone, enabling geographic reach across hospitals and clinics. These firms compete not only on price and supply reliability but also on product performance metrics including knot security, tissue drag, and resorption timelines. The competitive landscape reflects a blend of legacy brands expanding their reach via acquisitions and OEM arrangements.
Ethicon and Medtronic dominate absorbable-suture volumes, with Ethicon (HQ: New Brunswick, USA) offering Vicryl, Monocryl, and PDS for closures. Medtronic (HQ: Dublin, Ireland) uses Covidien-derived absorbables to maintain a portfolio. B. Braun Melsungen AG (HQ: Melsungen, Germany) extends access through regional plants and a diversified supplier network. Weigao Group Medical Polymer Co., Ltd. (HQ: Weihai, China) has scaled suture production to meet APAC demand and is expanding exports. Kanghui Medical Co., Ltd. (HQ: Shanghai, China) supports regional distribution and regulatory alignment in Asian markets. Meril Life Sciences Pvt. Ltd. (HQ: Ahmedabad, India) combines domestic manufacturing with expanding distribution in the Middle East and Africa. Taewoong Medical Co., Ltd. (HQ: Seoul, Korea) emphasizes quality and approvals in Korea. DemeTech Corporation (HQ: Miami, USA) maintains U.S.-centric manufacturing and sales. Lohmann & Rauscher (HQ: Rottendorf, Germany) supplies clinics with standardized sutures. Teleflex Incorporated (HQ: Wayne, USA) complements wound-management with devices for surgical applications.
Across these ten firms, market growth is driven by rising surgery volumes and preferences for predictable resorption timelines with minimal tissue reaction. Core polymers—polyglactin 910, polyglycolic acid, poliglecaprone, and polydioxanone—remain central, with firms investing in formulations balancing handling and knot security. Geographic diversification supports shorter supply chains across the United States, Europe, China, and India, while maintaining regulatory alignment. Quality, sterility, and packaging innovations are key differentiators as reimbursement trends favor value-based care. The ten companies listed—Ethicon (HQ: New Brunswick, USA), Medtronic (HQ: Dublin, Ireland), B. Braun Melsungen AG (HQ: Melsungen, Germany), Weigao Group Medical Polymer Co., Ltd. (HQ: Weihai, China), Kanghui Medical Co., Ltd. (HQ: Shanghai, China), Meril Life Sciences Pvt. Ltd. (HQ: Ahmedabad, India), Taewoong Medical Co., Ltd. (HQ: Seoul, Korea), DemeTech Corporation (HQ: Miami, USA), Lohmann & Rauscher (HQ: Rottendorf, Germany), Teleflex Incorporated (HQ: Wayne, USA)—will continue to influence standards through evidence and compliance in surgical care.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
